Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
AbbVie 115.28 -1.61 -1.38% 10.80%
Akebia Therapeutics 2.71 0.09 3.44% -12.86%
Alexion Pharmaceuticals 182.50 0 0% 70.54%
Amgen 198.88 -4.59 -2.26% -11.64%
Arena Pharmaceuticals 54.49 -0.47 -0.86% -17.58%
Bayer 44.52 -0.80 -1.77% -8.54%
Bluebird Bio 10.11 -0.22 -2.13% -77.96%
BioMarin Pharmaceutical 86.29 -1.11 -1.27% 8.54%
Clovis Oncology 3.16 0.07 2.27% -35.11%
Dicerna Pharmaceuticals 38.01 -0.07 -0.18% 53.51%
Exelixis 16.79 -0.12 -0.71% -12.37%
Gilead Sciences 68.93 -1.72 -2.43% 12.78%
GlaxoSmithKline 1,525.00 0 0% 10.43%
J&J 155.93 -3.82 -2.39% 5.75%
Karyopharm Therapeutics 6.95 0.10 1.46% -58.92%
Eli Lilly 248.04 -6.79 -2.66% 70.40%
Mirati Therapeutics 136.77 0.77 0.57% -41.64%
Neurocrine Biosciences 83.25 -1.49 -1.76% -12.21%
Novartis 73.44 -0.80 -1.08% -9.75%
Puma Biotechnology 3.10 0.02 0.65% -74.10%
Pfizer 53.73 1.33 2.54% 36.34%
PTC Therapeutics 37.16 0.27 0.73% -40.82%
Ultragenyx Pharmaceutical 75.23 1.52 2.06% -35.91%
Regeneron Pharmaceuticals 636.53 -17.87 -2.73% 23.82%
Rigel Pharmaceuticals 2.67 -0.03 -1.11% -11.59%
Sangamo BioSciences 8.29 0.07 0.85% -17.84%
TG Therapeutics 15.20 -8.16 -34.93% -45.93%
United Therapeutics 189.50 -4.50 -2.32% 43.03%
Vertex Pharmaceuticals 186.94 -3.17 -1.67% -18.83%
Acceleron Pharma 178.75 -0.93 -0.52% 57.43%

Indexes Price Day Year
NASDAQ 15538 -245.14 -1.55% 25.76%
US2000 2199 -43.07 -1.92% 19.76%

Acceleron Pharma
Acceleron Pharma Inc. is a biopharmaceutical company. The Company is focused on its research, development, and commercialization efforts in pulmonary and hematologic diseases. Its research is focused on key natural regulators of cellular growth and repair, particularly the Transforming Growth Factor-Beta (TGF-beta) protein superfamily. The Company's product pipeline includes Sotatercept, ACE-1334 and REBLOZYL (luspatercept-aamt). Its lead pulmonary program, Sotatercept, is an activin receptor type IIA fusion protein that is used for the treatment of patients with pulmonary arterial hypertension (PAH). ACE-1334 is a wholly owned TGF-beta superfamily-based ligand trap designed to bind and inhibit TGF-beta 1 and 3 ligands but not TGF-beta 2. Its REBLOZYL (luspatercept-aamt), is an erythroid maturation agent designed to promote red blood cell (RBC).